<DOC>
	<DOCNO>NCT01644526</DOCNO>
	<brief_summary>The ability selectively control blood flow arteriovenous ( AV ) graft need dialysis may reduce current repetitive complication thrombosis , venous hypertension blood steal extremity . The Hemoaccess Valve System ( HVS ) allow AV graft turn blood flow need dialysis dialysis conclude , device 's valve activate , shut flow blood graft . The graft flush sterile saline use dialysis blood line . By saline graft restore normal blood flow artery vein , believe dramatically reduce current complication blood divert graft 24/7 .</brief_summary>
	<brief_title>A Pilot Study To Evaluate The CreatiVasc Hemoaccess Valve System In Patients Requiring Arteriovenous Graft Placement</brief_title>
	<detailed_description>The Hemoaccess Valve System ( HVS ) subcutaneous valve device implant new AV graft place . It consist silicone port 3cc sterile saline inject . The fluid travel connective tube two balloon valve expand inside small rigid cuff surround end end graft venous arterial anastomosis . The expansion balloon inside cuff close graft blood flow . Once graft close , blood inside graft flush sterile saline use dialysis needle still place graft end dialysis . Once graft clear blood , sterile saline along heparin remain graft dialysis session . At next dialysis session , 3cc saline balloon valve aspirate , deflate valve allow blood flow graft dialysis . ( The saline inside graft simply enter blood stream . ) By saline inside AV graft dialysis session , post-dialysis bleeding dialysis needle cannulate , blood flow restore normal course vein artery , traditional turbulent blood flow graft eliminate , reduce traditional complication cause arterial blood divert graft vein .</detailed_description>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<criteria>Be candidate new arteriovenous graft Be either currently dialysis ready begin dialysis soon access device ( AV graft Hemoaccess Valve System ) ready use . Be prepared receive dialysis dialysis center Greenville , SC Bethesda , MD Have outflow vein great equal 3mm diameter graft successfully anastomose . Be able communicate study personnel . Be consider physician readily available subsequent visit . Be willing comply aspect treatment evaluation direct duration study . Allow representative Sponsor , designate Clinical Research Organization , Institutional Review Board FDA review his/her relevant medical record pertain study . An identification central venous stenosis ipsilateral side document otherwise identify An identification arterial venous stenosis ipsilateral side document otherwise identify A hypercoagulable state document otherwise identify and/or previous AV access failure occur without identifiable cause . Has life expectancy le one year . An immunodeficiency syndrome An organ transplant expect within 6 month enrollment They candidate natural fistula 3 previous new AV graft fistula placement occur . Body habitus ( e.g. , extremely small obese arm ( precludes HVS device implantation access .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>dialysis</keyword>
	<keyword>vascular access</keyword>
	<keyword>arteriovenous graft</keyword>
	<keyword>valve system</keyword>
</DOC>